BioSig Technologies Common Performance

BSGMDelisted Stock  USD 6.10  1.74  39.91%   
The firm shows a Beta (market volatility) of -1.72, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning BioSig Technologies, are expected to decrease by larger amounts. On the other hand, during market turmoil, BioSig Technologies, is expected to outperform it. BioSig Technologies, right now shows a risk of 0.0%. Please confirm BioSig Technologies, sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if BioSig Technologies, will be following its price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days BioSig Technologies Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, BioSig Technologies, is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
  

BioSig Technologies, Relative Risk vs. Return Landscape

If you would invest  610.00  in BioSig Technologies Common on November 5, 2025 and sell it today you would earn a total of  0.00  from holding BioSig Technologies Common or generate 0.0% return on investment over 90 days. BioSig Technologies Common is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than BioSig, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

BioSig Technologies, Target Price Odds to finish over Current Price

The tendency of BioSig OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 6.10 90 days 6.10 
about 40.6
Based on a normal probability distribution, the odds of BioSig Technologies, to move above the current price in 90 days from now is about 40.6 (This BioSig Technologies Common probability density function shows the probability of BioSig OTC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days BioSig Technologies Common has a beta of -1.72 suggesting as returns on its benchmark rise, returns on holding BioSig Technologies Common are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, BioSig Technologies, is expected to outperform its benchmark. Additionally BioSig Technologies Common has an alpha of 0.5417, implying that it can generate a 0.54 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   BioSig Technologies, Price Density   
       Price  

Predictive Modules for BioSig Technologies,

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioSig Technologies,. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
6.106.106.10
Details
Intrinsic
Valuation
LowRealHigh
5.835.836.71
Details
Naive
Forecast
LowNextHigh
5.975.975.97
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.804.865.92
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BioSig Technologies,. Your research has to be compared to or analyzed against BioSig Technologies,'s peers to derive any actionable benefits. When done correctly, BioSig Technologies,'s competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BioSig Technologies,.

BioSig Technologies, Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BioSig Technologies, is not an exception. The market had few large corrections towards the BioSig Technologies,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioSig Technologies Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioSig Technologies, within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.54
β
Beta against Dow Jones-1.72
σ
Overall volatility
1.64
Ir
Information ratio 0.04

BioSig Technologies, Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioSig Technologies, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioSig Technologies, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BioSig Technologies, is now traded under the symbol STEX. Please update your portfolios or report it if you believe this is an error. Report It!
BioSig Technologies, is not yet fully synchronised with the market data
BioSig Technologies, has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 18 K. Net Loss for the year was (28.69 M) with profit before overhead, payroll, taxes, and interest of 242 K.
BioSig Technologies Common currently holds about 887 K in cash with (17.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 18.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Acquisition by Neil McFarlane of 125000 shares of Zevra Therapeutics subject to Rule 16b-3

BioSig Technologies, Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioSig OTC Stock often depends not only on the future outlook of the current and potential BioSig Technologies,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioSig Technologies,'s indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding7.4 M
Cash And Short Term Investments293 K

BioSig Technologies, Fundamentals Growth

BioSig OTC Stock prices reflect investors' perceptions of the future prospects and financial health of BioSig Technologies,, and BioSig Technologies, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioSig OTC Stock performance.

About BioSig Technologies, Performance

By examining BioSig Technologies,'s fundamental ratios, stakeholders can obtain critical insights into BioSig Technologies,'s financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that BioSig Technologies, is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.

Things to note about BioSig Technologies, performance evaluation

Checking the ongoing alerts about BioSig Technologies, for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for BioSig Technologies, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BioSig Technologies, is now traded under the symbol STEX. Please update your portfolios or report it if you believe this is an error. Report It!
BioSig Technologies, is not yet fully synchronised with the market data
BioSig Technologies, has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 18 K. Net Loss for the year was (28.69 M) with profit before overhead, payroll, taxes, and interest of 242 K.
BioSig Technologies Common currently holds about 887 K in cash with (17.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 18.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Acquisition by Neil McFarlane of 125000 shares of Zevra Therapeutics subject to Rule 16b-3
Evaluating BioSig Technologies,'s performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BioSig Technologies,'s otc stock performance include:
  • Analyzing BioSig Technologies,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioSig Technologies,'s stock is overvalued or undervalued compared to its peers.
  • Examining BioSig Technologies,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BioSig Technologies,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioSig Technologies,'s management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of BioSig Technologies,'s otc stock. These opinions can provide insight into BioSig Technologies,'s potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BioSig Technologies,'s otc stock performance is not an exact science, and many factors can impact BioSig Technologies,'s otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.
Note that the BioSig Technologies, information on this page should be used as a complementary analysis to other BioSig Technologies,'s statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in BioSig OTC Stock

If you are still planning to invest in BioSig Technologies, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioSig Technologies,'s history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities